GE HealthCare
GE HealthCare (GEHC) is a publicly traded Imaging & Diagnostics AI company founded in 2023 and based in Chicago, United States.
GE HealthCare became an independent public company on Jan. 3, 2023, when General Electric completed its spin-off, and it trades on Nasdaq as GEHC. It is headquartered in Chicago and traces its medical-technology business back about 130 years. It sells medical technology, pharmaceutical diagnostics, and AI, cloud and software products through three segments: Advanced Imaging Solutions, Patient Care Solutions and Pharmaceutical Diagnostics. It describes itself as a $20.6B business with about 54,000 employees. Second-quarter 2026 revenue rose 5.7% to $5.3B, and the company said it was reviewing strategic options for Patient Care Solutions. On March 18, 2026, it completed its $2.3B cash purchase of Intelerad, a cloud enterprise-imaging software company that it expects to bring in about $270M of revenue in a full year of ownership, about 90% of it recurring.
GE HealthCare had 100 authorizations on the FDA's list of AI-enabled medical devices as of July 2025 and targets more than 200 by 2028, across oncology, cardiology and neurology imaging. It ships that AI inside its own MRI, CT, PET/CT and ultrasound systems, so radiology departments get it with the scanner rather than from a separate vendor such as Aidoc or Viz.ai. The Intelerad purchase extends its imaging software into specialized clinics and ambulatory care.
At a glance
Total raised
Undisclosed
Headcount
10k+
Headquarters
Chicago
United StatesFounded
2023
Status
Public
Subsector
Health Tech, ranked
Top 25 Health Tech companies →Funding history
Total raised
—
Rounds tracked
0
No dated funding rounds on file. This company is privately held and may be raising or operating on undisclosed capital.
